Hepatic glycerol shunt and glycerol-3-phosphate phosphatase control liver metabolism and glucodetoxification under hyperglycemia

被引:8
作者
Al-Mass, Anfal [1 ,2 ,3 ,4 ,5 ]
Fi, Pegah Pourshari [2 ,3 ,4 ,5 ]
Lussier, Roxane [2 ,3 ,4 ,5 ]
Chenier, Isabelle [2 ,3 ,4 ,5 ]
Leung, Yat Hei [2 ,3 ,4 ,5 ]
Ghosh, Anindya [2 ,3 ,4 ,5 ]
Oppong, Abel [2 ,3 ,4 ,5 ]
Possik, Elite [2 ,3 ,4 ,5 ]
Mugabo, Yves [2 ,3 ,4 ,5 ]
Ahmad, Rasheed [6 ,7 ]
Sladek, Robert [1 ]
Madiraju, S. R. Murthy [2 ,3 ,4 ,5 ,9 ]
Al-Mulla, Fahd [6 ,7 ]
Prentki, Marc [2 ,3 ,4 ,5 ,8 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] Univ Montreal, Dept Nutr, Montreal, PQ, Canada
[3] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada
[4] Montreal Diabet Res Ctr, Montreal, PQ, Canada
[5] CRCHUM, Montreal, PQ, Canada
[6] Dasman Diabet Inst, Dept Immunol, Dasman 15462, Kuwait
[7] Dasman Diabet Inst, Dept Microbiol Genet & Bioinformat, Dasman 15462, Kuwait
[8] Univ Montreal CRCHUM, Biochem & Mol Med, Room R08-412, Tour Viger, 900 rue St Denis, Montreal, PQ H2X 0A9, Canada
[9] CRCHUM, Room R08-418, Tour Viger, 900 rue St Denis, Montreal, PQ H2X 0A9, Canada
基金
加拿大健康研究院;
关键词
Glycerol-3-phosphate phosphatase; Glycerol shunt; Glucodetoxification; Liver; Lipogenesis; Triglycerides; Cholesterol; Glycogen; Inflammation; NAFLD; INSULIN-RESISTANCE; FATTY; STRESS; CELL; GLUCONEOGENESIS; DISEASE; OBESITY; HEALTH; MICE;
D O I
10.1016/j.molmet.2022.101609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Glycerol-3-phosphate (Gro3P) phosphatase (G3PP) hydrolyzes Gro3P to glycerol that exits the cell, thereby operating a "glycerol shunt", a metabolic pathway that we identified recently in mammalian cells. We have investigated the role of G3PP and the glycerol shunt in the regulation of glucose metabolism and lipogenesis in mouse liver.Methods: We generated hepatocyte-specific G3PP-KO mice (LKO), by injecting AAV8-TBG-iCre to male G3PPfl/fl mice. Controls received AAV8TBG-eGFP. Both groups were fed chow diet for 10 weeks. Hyperglycemia (16-20 mM) was induced by glucose infusion for 55 h. Hepatocytes were isolated from normoglycemic mice for ex vivo studies and targeted metabolomics were measured in mice liver after glucose infusion.Results: LKO mice showed no change in body weight, food intake, fed and fasted glycemia but had increased fed plasma triglycerides. Hepatic glucose production from glycerol was increased in fasted LKO mice. LKO mouse hepatocytes displayed reduced glycerol production, elevated triglyceride and lactate production at high glucose concentration. Hyperglycemia in LKO mice led to increased liver weight and accumulation of triglycerides, glycogen and cholesterol together with elevated levels of Gro3P, dihydroxyacetone phosphate, acetyl-CoA and some Krebs cycle intermediates in liver. Hyperglycemic LKO mouse liver showed elevated expression of proinflammatory cytokines and M1-macrophage markers accompanied by increased plasma triglycerides, LDL/VLDL, urea and uric acid and myocardial triglycerides.Conclusions: The glycerol shunt orchestrated by G3PP acts as a glucose excess detoxification pathway in hepatocytes by preventing metabolic disturbances that contribute to enhanced liver fat, glycogen storage, inflammation and lipid build-up in the heart. We propose G3PP as a novel therapeutic target for hepatic disorders linked to nutrient excess.(c) 2022 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:12
相关论文
共 45 条
[1]   Glycerol-3-phosphate phosphatase operates a glycerol shunt in pancreatic β-cells that controls insulin secretion and metabolic stress [J].
Al-Mass, Anfal ;
Pourshari, Pegah ;
Peyot, Marie-Line ;
Lussier, Roxane ;
Levens, Emily J. ;
Guida, Julian ;
Mugabo, Yves ;
Possik, Elite ;
Ahmad, Rasheed ;
Al-Mulla, Fahd ;
Sladek, Robert ;
Madiraju, S. R. Murthy ;
Prentki, Marc .
MOLECULAR METABOLISM, 2022, 60
[2]   Recent insights on the role of cholesterol in non-alcoholic fatty liver disease [J].
Arguello, Graciela ;
Balboa, Elisa ;
Arrese, Marco ;
Zanlungo, Silvana .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (09) :1765-1778
[3]  
Bekkevold CM, 2013, J AM ASSOC LAB ANIM, V52, P233
[4]   Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes [J].
Birkenfeld, Andreas L. ;
Shulman, Gerald I. .
HEPATOLOGY, 2014, 59 (02) :713-723
[5]   Insulin Resistance in Nonalcoholic Fatty Liver Disease [J].
Bugianesi, E. ;
Moscatiello, S. ;
Ciaravella, M. F. ;
Marchesini, G. .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (17) :1941-1951
[6]  
Cassim Shamir, 2018, Oncotarget, V9, P26868, DOI 10.18632/oncotarget.25525
[7]   The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis [J].
Chen, Yaxi ;
Varghese, Zac ;
Ruan, Xiong Z. .
GENES & DISEASES, 2014, 1 (01) :106-112
[8]   Collection of mouse urine for bioassays [J].
Chew, JL ;
Chua, KY .
LAB ANIMAL, 2003, 32 (07) :48-50
[10]   Hepatic steatosis: Innocent bystander or guilty party? [J].
Day, CP ;
James, OFW .
HEPATOLOGY, 1998, 27 (06) :1463-1466